fields indicates that phenotypic variation among individuals and among somatic cells increases with age [1] [2] [3] [4] [5] . However, no evidence for an age-dependent increase in variation in gene expression has yet been found [6] [7] [8] [9] . Using eight microarray data sets from different studies in humans and rats, we find that gene expression becomes more variable with advancing age. This age-correlated heterogeneity of expression (ACHE) has a minor effect on individual genes, but is widespread throughout the transcriptome. We find no evidence for ACHE being caused by germline mutations or by differences in aging rates between individuals. However, our results are compatible with ACHE being an outcome of the accumulation of stochastic effects at the cellular level.
We designed a statistical test that measures an increase in expression heterogeneity with age. ACHE is calculated separately for each probe set (a probe set detects one mRNA transcript in microarray experiments). We tested eight microarray data sets, including data from human kidney (cortex and medulla), human skeletal muscle, post-mortem human cerebral cortex and rat hippocampus, for an excess of probe sets showing ACHE (Figure 1 ). The random expectation was calculated through permutations (see Supplemental Data published with this article online).
We found that the proportion of probe sets showing a positive correlation between age and expression variation (at ACHE test p ≤ 0.05) was more than expected in seven of the eight data sets ( Figure 1D ). In four of these data sets, the excess was significant (permutation test p ≤ 0.01), resulting in an overall significance of p = 7×10 -7 Age correlated homogeneity at P > 0.95
Age correlated heterogeneity at P < 0.50
D Significance of the ACHE tendency among the data sets
Age correlated heterogeneity at P 0.05 (A) Age distribution of subjects in the data sets. Human ages are given in years, rat ages in months. In parentheses, the number of subjects is given as 'N', the number of probe sets used in quantitative ACHE analyses is given as 'n'. The ACHE test for increase in heterogeneity with age is conducted on each probe set independently and makes use of regression models between expression level and age [14] 
(Supplemental Data). (B)
An example from the human brain data set B, the log-expression versus age plot for a probe set detecting the gene PIM-1, for which the ACHE test p-value was calculated as 0.0002. Medawar's germline mutation accumulation theory of aging [3] provides a possible explanation for ACHE. Because old individuals contribute less to the next generation than the young, the force of purifying selection on the old phenotype is weaker. Therefore, a deleterious germline mutation that affects gene expression only at old age will have a higher probability of remaining within the population than other mutations. What we are observing as ACHE could therefore be a signature of this old-age-specific genetic heterogeneity. However, a genetically homogenous rat population also displayed significant ACHE ( Figure 1D) . Thus, the germline mutation accumulation theory cannot fully account for the ACHE effect.
Another possible source of ACHE are differences in aging rates between individuals [10] . If expression profiles are similar among young individuals, but then change at different rates due to genetic or environmental variation, the expression profiles of the old will be relatively heterogeneous. To evaluate this hypothesis, we assigned an 'expression age' to each individual for each gene, according to expression level [11] (Supplemental Data). Expression ages derived from independent sets of genes were tightly correlated, implying that, within an individual, the vast majority of genes change their expression levels with age at similar rates. However, we did not detect a significant age-related increase in the absolute differences between mean expression ages and chronological ages, which we would expect if differences in aging rates were reflected in gene expression.
Our results indicate that ACHE is a general -but weak -effect in the transcriptome. This is compatible with ACHE being the outcome of accumulating stochastic effects in the soma, such as cellular damage and mutations. These effects will influence each cell in a unique way [2] so that expression variation among aging cells will be equalized at the tissue level. If somatic mutations mostly cause decreases in expression level [12] , the overlap between ACHE and age-related decrease in expression levels can also be explained within this framework. ACHE supports the stochastic nature attributed to the aging process [10] . It implies a weakening of expression regulation with age, contrary to previous observations and hypotheses based on measurements on a small number of genes [6, 13] . The extent of ACHE among single cells and the role of ACHE in aging remains to be determined.
